BioSpace News Archive

Egg Donation Market is set to See Impressive Growth to 2031, Says TMR

Significant growth in the issues pertaining to fertility across the globe is expected to work as one of the key drivers for the development of global egg donation market during the forecast period 2021–2031.

September 16, 2021
·
5 min read
Clinical Reference Laboratory Services Market Study Report | Latest Trends and Future Scope Analysis

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others.

September 16, 2021
·
6 min read
Cell Lysis and Disruption Market Report | Exclusive Report on the Latest Trends and Opportunities in the Market

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.

September 16, 2021
·
5 min read
Drug Development

Acepodia Presents Positive Interim Phase 1 Feasibility Data for Antibody Cell Effector Therapy, ACE1702, in Advanced HER2-Positive Tumors

Acepodia reported new interim data from an ongoing Phase 1 dose escalation study demonstrating feasibility with ACE1702, the company’s most advanced investigational antibody effector cell therapy, in development for patients with advanced HER2-positive tumors.

September 16, 2021
·
6 min read
Drug Development

Transgene Presents Data From Phase I Clinical Trial Confirming the Potential of the Oncolytic Virus TG6002

Transgene announces the presentation of data from a Phase I study combining intravenous oncolytic virus TG6002 and oral 5-FC in patients with advanced gastrointestinal carcinomas at the European Society for Medical Oncology virtual meeting taking place from September 16-21, 2021.

September 16, 2021
·
8 min read
Business

Launch of Oxitope Pharma, a biopharmaceutical start-up dedicated to the discovery and development of antibody-based medicines for the treatment of diseases caused by oxidative stress

Oxitope Pharma B.V., a company committed to enabling people to live longer and healthier lives by treating diseases driven by oxidative stress, announces its official launch after having been operational since March 2020.

September 16, 2021
·
4 min read
Medivir invites to a conference call on new clinical data and further studies with MIV-818

Medivir AB invites to a conference call on the supporting clinical data from the completed dose escalation section of the phase 1b study with MIV-818, presented at the European Society for Medical Oncology congress.

September 16, 2021
·
4 min read
Genetown

Crescendo to Participate in Upcoming Investor Conferences - Sep 16, 2021

Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announces that senior members of the executive team will be participating at the following events.

September 16, 2021
·
2 min read
Drug Development

Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase 1/1b Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors

Silverback Therapeutics, Inc. presented interim clinical results from a Phase 1/1b clinical study of SBT6050 as a monotherapy and in combination with pembrolizumab in patients with advanced or metastatic HER2-expressing or amplified solid tumors, at the 2021 European Society for Medical Oncology Congress.

September 16, 2021
·
7 min read
Pharm Country

Laekna Therapeutics reported positive results in two clinical studies for the treatment of various stages of prostate cancer at the ESMO Congress

Laekna Therapeutics reported positive results in two clinical studies for the treatment of early and late stages of prostate cancer respectively at the European Society for Medical Oncology Congress 2021.

September 16, 2021
·
7 min read